Crisis Prevention and Recovery LLC does business as SoftwareCPR®. SoftwareCPR® consists of several partners who are experts in FDA regulation (and ISO standards) in general, and medical device software in particular. Most of our partners and affiliates are former practitioners – they were in the trenches at one time developing and/or qualifying medical devices and the software associated with those products. Our experience ranges from deeply embedded software to SaMD running on standard platforms, from complex control algorithms to user interface graphical software, and from the test lab to the executive board room. We have many years of experience – most of our partners have been in this industry for over 30 years! Well seasoned we like to say.
We can get to the core issues quickly and save you time and money. We do not use a one-size-fits-all approach – we seek first to understand our clients’ culture, what makes their products unique, and how quality assurance already exists in their DNA. Our support can range from strategic advice on regulatory classification to full hands-on remediation of any quality system documentation or records. We even can provide many types of design verification and usability evaluations.
SoftwareCPR® is best known for software, regulatory, risk management, validation, and 21 CFR Part 11 consultation for medical device, pharmaceutical, and blood establishment computer system manufacturers. We also provide full FDA enforcement action crisis recovery, premarket submission, and quality system training and consulting services with a focus on client culture, business goals, and efficiency as well as device safety and effectiveness.
SoftwareCPR® has provided internal Software Validation and Risk Management Training to FDA and Health Canada and SoftwareCPR® partners frequently teach with FDA co-instructors.
Individual credential PDF files can be downloaded by clicking on the photos and/or the link icon.
Full service regulatory consulting, including FDA interaction, standards compliance, lean/agile medical device software processes, expert with IEC 62304, IEC 80002-1, AAMI TIR45, software hazards analysis, verification and validation testing, training, coaching & mentoring.
John is a 25 year FDA veteran. John served as a regulatory and compliance expert for FDA regulated computers and software. Practice (focus) areas include FDA software related guidances, software device classification determination, pre-market software review, post market software inspectional 483’s, additional information software requests, Digital Health Pre-certification, AAMI Software related TIRs and related medical device software standards.
Led the first AI-enabled De Novo approval of SaMD. Former Chief Quality and Regulatory Officer, Management Representative under ISO 13485, Person Responsible for Regulatory Compliance under EU MDR, Lead auditor for ISO 13485 (MDR, MHLW Ordinance No. 169), and recently assisted Massachusetts General Brigham’s Digital CRO activities related to FDA. Senior expert with pre-subs, De Novo and 510(k) submissions, strategy, FDA negotiation and interaction.
Ginny is a regulatory affairs professional specializing in software-based products starting in 2011. She has experience in the regulated industry including medical devices, pharmaceuticals and biotechnology.
Ginny has developed regulatory strategies for a variety of SiMD/SaMD and AI/ML-based products during her career at start-ups, mid-size companies and global enterprises. She has worked on US regulatory submissions including Q-Sub, 510(k) and PMA and has supported a variety of global submissions. Ginny is known for both strategic and tactical support including hands-on, close collaboration with frequent-release agile development teams. Ginny’s professional objectives are driven by her personal goal to expedite the development and approval of quality medical products into medical markets.
Dr Rech has over 20 years experience in systems and safety engineering in regulated industries in individual contributor and management roles. He has worked with Class II and III medical devices including implantable pacemakers, infusion pumps, and remote monitoring devices and apps. He held certificates as INCOSE Certified Systems Engineering Professional and TUV Rheinland Certified Functional Safety Engineer. He holds a Doctor of Philosophy (PhD), Physical Chemistry, Free University Berlin, and speaks English, German, and French.
Mike is an expert in business agility and is key to our “agile and compliant” process transformation and improvements. Mike served on the TIR working group that created the AAMI TIR45- 2012 Technical Information Report Guidance on the use of Agile practices in the development of medical device software. Mike combines experience serving as both a C-level executive, including as Chief Operations Officer for a top 60 U.S. bank, and as a trusted advisor to CEOs and other top executives at diverse organizations in multiple industries. This has provided him with first-hand experience dealing with many opportunities and challenges facing executives today, especially with rapid change and digital transformation. For example, while leading a product division, Mike introduced changes that resulted in improved productivity by 15%, cut time-to-market by up to 67%, and reduced defects by over 50% in flagship products processing of over $80 billion in financial transactions per year.
Jordan performs IEC 62304 and ISO 14971 audits, assessments, and first level remediation work with requirements, architecture, plans, and test assets, electronics/mechanical technical and construction of test fixtures, and test automation support.
Jordan brings a wealth of risk management experience as a practitioner and leader. He works daily with clients to ensure compliance with standards and FDA expectations.
*Note: Partner is a title describing a branding and marketing partnership and does not indicate ownership or corporate structure.
Annette has been a regulatory affairs consultant since 1998. Prior to consulting, she was Director, Regulatory Affairs, for Critikon, a Johnson & Johnson Company, where she worked with cardiovascular monitoring devices. She has over 25 years experience in regulatory affairs, compliance and clinical affairs with prior experiences in the implantable cardiovascular and ophthalmic devices industries. Her worldwide regulatory affairs responsibilities have included FDA submissions, GMP/QS compliance, interpretation of all FDA regulations and policies, regulatory representation on new product development teams, product liability and international product registrations. She has also represented Johnson & Johnson on several software related FDA/industry guidance and standards-setting activities.
Annette is Regulatory Affairs Certified and holds BA degrees in biology, microbiology and secondary science education.
Robert is a former Principal Scientist with GE Healthcare and has 40+ years’ experience in medical device software and systems development. He as designed and implemented ECG, blood pressure, and other signal processing systems in research and product development settings. He has a long track record of understanding quality assurance, both from a compliance perspective but also from success at delivery production-ready, robust medical devices used globally. Robert is a member of the AAMI Sphygmomanometer Committee, AAMI ECG/Arrhythmia Monitoring Working Group, and AAMI ECG/Ambulatory Electrocardiograph Working Group.
Expertise includes organizational development, culture assessment, change management, people assessment and coaching.
To foster greater margins of safety, effectiveness, compliance, and profit through better software risk management, acquisition, development, validation, and maintenance.